新西兰骨髓瘤患者赴上海参加CAR-T临床试验，含机票总费用约6.5万美元
- When
- 2025-05
- City
- Shanghai
- 自报总费用
- about $65,000 (as reported)
- Shared on
- News
- Patient from
- New Zealand
有报道最后核验
时间线
2018
Diagnosed with high-risk myeloma; later three stem cell treatments in New Zealand.
2025
Relapses; CAR-T not commercially available at home and Australian cost could exceed A$500,000.
2025-05
Within about 10 days of contact, admitted to Renji Hospital, Shanghai.
2025
Seven weeks in China, five in hospital; dual CAR-T in a clinical trial; reports complete remission.
顺利之处
- 入组接受速度快
- 含医院治疗和机票在内总费用约6.5万美元（彭博社报道）
- 据其自述已缓解，每月血液检查结果稳定
困难之处
- 不得不通过募款筹集费用
- 治疗以临床试验形式进行；他表示这并非治愈手段
Individual experience; outcomes vary. This story is a summary linking to its source; follow the link for the original account.
来源
本站仅提供信息，不构成医疗建议、诊断或治疗推荐。请咨询你的医生。紧急情况请立即拨打当地急救电话。